Did anyone see the list of mabs mentioned in this paragraph of the WSJ article?

"Covid-19 clinical trials are now under way for 10 new monoclonal antibodies, known as mAbs in industry jargon, according to the Antibody Society, a professional association of researchers."

I called the Antibody Society a few days ago and they know about Leronlimab and know about the submission of the results of the Phase 2 study to the FDA.

I will be really pissed if they didn't include Leronlimab in that list!